A Study of QLS2404 Injection in Healthy Participants and Participants With Rheumatic Autoimmune Diseases

Clinical trial NCT07751315 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07751315
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Primary Sjögren's Syndrome

Start date: 2026-08-11
Primary completion: 2027-11-07
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.